2026 Biosimilars Compounding 
Express Pharma
JANUARY 11, 2024
The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 Canakinumb, set for a 2030 launch, is a biosimilar to the established Ilaris therapy. per cent from $4.6 billion in 2022 to $10.8
FDA Law Blog: Biosimilars
FEBRUARY 2, 2025
This also includes additional requirements for pharmacies that engage in sterile and complex nonsterile compounding. California pharmacists are still able to provide the oral therapeutics without requiring you to visit your primary care physician through January 1, 2026.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
NOVEMBER 2, 2023
Though the entry of biosimilars will contract the market, significant growth is expected over the next 8-10 years, driven by the launch of new assets. Against this backdrop, the CD drug sales across the eight-major markets (8MM*) are set to increase at a compound annual growth rate (CAGR) of 4.7 per cent from $9.5
Pharmaceutical Technology
JANUARY 10, 2023
Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).
FDA Law Blog: Biosimilars
DECEMBER 3, 2023
On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. The Discount Program is similar to the CGDP with respect to several requirements and operational processes, and CMS will implement it in a similar manner.
Pharmacy Times
JUNE 4, 2025
USP labs provide unparalleled expertise in developing quality and process standards, establishing and validating analytical methods, characterizing impurities, and synthesizing organic compounds. USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. Subscribe Now!
Pharmacy Times
JUNE 10, 2025
Pharmacy schools are expected to graduate 8,000 student pharmacists in 2026…” [Instagram post]. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025. aacpharmacy. March 12, 2025. Accessed June 6, 2025.
Expert insights. Personalized for you.
103 
Let's personalize your content